Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.

Bennett, Jason W

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy. [electronic resource] - PLoS neglected tropical diseases Feb 2016 - e0004423 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1935-2735

10.1371/journal.pntd.0004423 doi


Adolescent
Adult
Antibodies, Protozoan--immunology
Female
Humans
Malaria Vaccines--administration & dosage
Malaria, Vivax--immunology
Male
Middle Aged
Plasmodium vivax--immunology
Protozoan Proteins--administration & dosage
Vaccination
Young Adult